Literature DB >> 12142461

A clogged gutter mechanism for protease inhibitors.

Evette S Radisky1, Daniel E Koshland.   

Abstract

A classical peptide inhibitor of serine proteases that is hydrolyzed approximately 10(7) times more slowly than a good substrate is shown to form an acyl-enzyme intermediate rapidly. Despite this quick first step, further reaction is slowed dramatically because of tight and oriented binding of the cleaved peptide, preventing acyl-enzyme hydrolysis and favoring the reverse reaction. Moreover, this mechanism appears to be common to a large class of tight-binding serine protease inhibitors that mimic good substrates. The arrest of enzymatic reaction at the intermediate stage allowed us to determine that the consensus nucleophilic attack angle is close to 90 degrees in the reactive Michaelis complexes.

Mesh:

Substances:

Year:  2002        PMID: 12142461      PMCID: PMC124911          DOI: 10.1073/pnas.112332899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  The serine protease inhibitor canonical loop conformation: examples found in extracellular hydrolases, toxins, cytokines and viral proteins.

Authors:  R M Jackson; R B Russell
Journal:  J Mol Biol       Date:  2000-02-18       Impact factor: 5.469

2.  Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.

Authors:  C Longstaff; A F Campbell; A R Fersht
Journal:  Biochemistry       Date:  1990-08-07       Impact factor: 3.162

3.  Mechanisms of temporary inhibition in Streptomyces subtilisin inhibitor induced by an amino acid substitution, tryptophan 86 replaced by histidine.

Authors:  A Tamura; K Kanaori; S Kojima; I Kumagai; K Miura; K Akasaka
Journal:  Biochemistry       Date:  1991-05-28       Impact factor: 3.162

4.  Variability of the canonical loop conformations in serine proteinases inhibitors and other proteins.

Authors:  W Apostoluk; J Otlewski
Journal:  Proteins       Date:  1998-09-01

5.  Engineered eglin c variants inhibit yeast and human proprotein processing proteases, Kex2 and furin.

Authors:  T Komiyama; R S Fuller
Journal:  Biochemistry       Date:  2000-12-12       Impact factor: 3.162

6.  Deciphering the role of the electrostatic interactions involving Gly70 in eglin C by total chemical protein synthesis.

Authors:  W Y Lu; M A Starovasnik; J J Dwyer; A A Kossiakoff; S B Kent; W Lu
Journal:  Biochemistry       Date:  2000-04-04       Impact factor: 3.162

7.  Refined crystal structure of the molecular complex of Streptomyces griseus protease B, a serine protease, with the third domain of the ovomucoid inhibitor from turkey.

Authors:  M Fujinaga; R J Read; A Sielecki; W Ardelt; M Laskowski; M N James
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

8.  Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues.

Authors:  P D Martin; M G Malkowski; J DiMaio; Y Konishi; F Ni; B F Edwards
Journal:  Biochemistry       Date:  1996-10-08       Impact factor: 3.162

9.  Backbone dynamics of chymotrypsin inhibitor 2: effect of breaking the active site bond and its implications for the mechanism of inhibition of serine proteases.

Authors:  G L Shaw; B Davis; J Keeler; A R Fersht
Journal:  Biochemistry       Date:  1995-02-21       Impact factor: 3.162

10.  Refined crystal structure of the complex of subtilisin BPN' and Streptomyces subtilisin inhibitor at 1.8 A resolution.

Authors:  Y Takeuchi; Y Satow; K T Nakamura; Y Mitsui
Journal:  J Mol Biol       Date:  1991-09-05       Impact factor: 5.469

View more
  53 in total

1.  High affinity small protein inhibitors of human chymotrypsin C (CTRC) selected by phage display reveal unusual preference for P4' acidic residues.

Authors:  András Szabó; Dávid Héja; Dávid Szakács; Katalin Zboray; Katalin A Kékesi; Evette S Radisky; Miklós Sahin-Tóth; Gábor Pál
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Cyclic, linear, cycloretro-isomer, and cycloretro-inverso peptides derived from the C-terminal sequence of bradykinin as substrates or inhibitors of serine and cysteine proteases.

Authors:  Aurelio Resende Lima; Luiz Juliano; Maria Aparecida Juliano
Journal:  Protein J       Date:  2004-05       Impact factor: 2.371

Review 3.  The many faces of protease-protein inhibitor interaction.

Authors:  Jacek Otlewski; Filip Jelen; Malgorzata Zakrzewska; Arkadiusz Oleksy
Journal:  EMBO J       Date:  2005-03-03       Impact factor: 11.598

4.  Protein-protein interactions as a tool for site-specific labeling of proteins.

Authors:  Marcus Jäger; Xavier Michalet; Shimon Weiss
Journal:  Protein Sci       Date:  2005-06-29       Impact factor: 6.725

5.  Insights into the serine protease mechanism from atomic resolution structures of trypsin reaction intermediates.

Authors:  Evette S Radisky; Justin M Lee; Chia-Jung Karen Lu; Daniel E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

6.  Exploring the role of structure and dynamics in the function of chymotrypsin inhibitor 2.

Authors:  Matthew J Whitley; Andrew L Lee
Journal:  Proteins       Date:  2010-12-22

7.  Functional and structural roles of the Cys14-Cys38 disulfide of bovine pancreatic trypsin inhibitor.

Authors:  Elena Zakharova; Martin P Horvath; David P Goldenberg
Journal:  J Mol Biol       Date:  2008-07-30       Impact factor: 5.469

8.  Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapy.

Authors:  Itay Cohen; Olumide Kayode; Alexandra Hockla; Banumathi Sankaran; Derek C Radisky; Evette S Radisky; Niv Papo
Journal:  Biochem J       Date:  2016-03-08       Impact factor: 3.857

9.  Amide Rotation Hindrance Predicts Proteolytic Resistance of Cystine-Knot Peptides.

Authors:  Yanzi Zhou; Daiqian Xie; Yingkai Zhang
Journal:  J Phys Chem Lett       Date:  2016-03-11       Impact factor: 6.475

10.  Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.

Authors:  Daniel C Pimenta; Sandro E Fogaça; Robson L Melo; Luiz Juliano; Maria A Juliano
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.